XML 76 R53.htm IDEA: XBRL DOCUMENT v3.23.2
Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jul. 02, 2023
Jul. 03, 2022
Jul. 02, 2023
Jul. 03, 2022
Sales by segment of business        
Sales to customers $ 25,530 $ 24,020 $ 50,276 $ 47,446
Percent Change (as a percent) 6.30%   6.00%  
U.S.        
Sales by segment of business        
Sales to customers $ 13,444 12,197 $ 25,961 23,611
Percent Change (as a percent) 10.20%   10.00%  
International        
Sales by segment of business        
Sales to customers $ 12,086 11,823 $ 24,315 23,835
Percent Change (as a percent) 2.20%   2.00%  
CONSUMER HEALTH        
Sales by segment of business        
Sales to customers $ 4,011 3,805 $ 7,863 7,391
Percent Change (as a percent) 5.40%   6.40%  
CONSUMER HEALTH | U.S.        
Sales by segment of business        
Sales to customers $ 1,787 1,687 $ 3,522 3,244
Percent Change (as a percent) 6.00%   8.60%  
CONSUMER HEALTH | International        
Sales by segment of business        
Sales to customers $ 2,224 2,118 $ 4,341 4,147
Percent Change (as a percent) 5.00%   4.70%  
CONSUMER HEALTH | OTC [Member]        
Sales by segment of business        
Sales to customers $ 1,659 1,482 $ 3,301 2,943
Percent Change (as a percent) 12.00%   12.20%  
CONSUMER HEALTH | OTC [Member] | U.S.        
Sales by segment of business        
Sales to customers $ 712 663 $ 1,457 1,333
Percent Change (as a percent) 7.50%   9.30%  
CONSUMER HEALTH | OTC [Member] | International        
Sales by segment of business        
Sales to customers $ 947 818 $ 1,844 1,609
Percent Change (as a percent) 15.70%   14.60%  
CONSUMER HEALTH | Skin Health/Beauty        
Sales by segment of business        
Sales to customers $ 1,148 1,126 $ 2,258 2,138
Percent Change (as a percent) 2.00%   5.60%  
CONSUMER HEALTH | Skin Health/Beauty | U.S.        
Sales by segment of business        
Sales to customers $ 650 629 $ 1,267 1,173
Percent Change (as a percent) 3.40%   8.00%  
CONSUMER HEALTH | Skin Health/Beauty | International        
Sales by segment of business        
Sales to customers $ 498 497 $ 991 965
Percent Change (as a percent) 0.30%   2.70%  
CONSUMER HEALTH | Oral Care        
Sales by segment of business        
Sales to customers $ 398 394 $ 759 760
Percent Change (as a percent) 0.90%   (0.20%)  
CONSUMER HEALTH | Oral Care | U.S.        
Sales by segment of business        
Sales to customers $ 173 170 $ 332 313
Percent Change (as a percent) 1.70%   6.20%  
CONSUMER HEALTH | Oral Care | International        
Sales by segment of business        
Sales to customers $ 225 224 $ 427 447
Percent Change (as a percent) 0.30%   (4.70%)  
CONSUMER HEALTH | Baby Care        
Sales by segment of business        
Sales to customers $ 360 375 $ 719 730
Percent Change (as a percent) (4.00%)   (1.60%)  
CONSUMER HEALTH | Baby Care | U.S.        
Sales by segment of business        
Sales to customers $ 99 88 $ 195 173
Percent Change (as a percent) 12.50%   12.70%  
CONSUMER HEALTH | Baby Care | International        
Sales by segment of business        
Sales to customers $ 261 287 $ 524 557
Percent Change (as a percent) (9.10%)   (6.00%)  
CONSUMER HEALTH | Women’s Health        
Sales by segment of business        
Sales to customers $ 238 230 $ 455 458
Percent Change (as a percent) 3.40%   (0.60%)  
CONSUMER HEALTH | Women’s Health | U.S.        
Sales by segment of business        
Sales to customers $ 4 3 $ 7 7
Percent Change (as a percent) (2.10%)   (0.10%)  
CONSUMER HEALTH | Women’s Health | International        
Sales by segment of business        
Sales to customers $ 235 228 $ 449 452
Percent Change (as a percent) 3.50%   (0.70%)  
CONSUMER HEALTH | Wound Care/Other        
Sales by segment of business        
Sales to customers $ 207 197 $ 371 361
Percent Change (as a percent) 4.90%   2.60%  
CONSUMER HEALTH | Wound Care/Other | U.S.        
Sales by segment of business        
Sales to customers $ 149 133 $ 264 245
Percent Change (as a percent) 12.30%   7.90%  
CONSUMER HEALTH | Wound Care/Other | International        
Sales by segment of business        
Sales to customers $ 58 65 $ 107 117
Percent Change (as a percent) (10.30%)   (8.40%)  
PHARMACEUTICAL        
Sales by segment of business        
Sales to customers $ 13,731 13,317 $ 27,144 26,186
Percent Change (as a percent) 3.10%   3.70%  
PHARMACEUTICAL | U.S.        
Sales by segment of business        
Sales to customers $ 7,818 7,159 $ 14,841 13,791
Percent Change (as a percent) 9.20%   7.60%  
PHARMACEUTICAL | International        
Sales by segment of business        
Sales to customers $ 5,913 6,158 $ 12,303 12,395
Percent Change (as a percent) (4.00%)   (0.70%)  
PHARMACEUTICAL | Immunology        
Sales by segment of business        
Sales to customers $ 4,496 4,411 $ 8,608 8,530
Percent Change (as a percent) 1.90%   0.90%  
PHARMACEUTICAL | Immunology | U.S.        
Sales by segment of business        
Sales to customers $ 2,865 2,853 $ 5,313 5,354
Percent Change (as a percent) 0.40%   (0.80%)  
PHARMACEUTICAL | Immunology | International        
Sales by segment of business        
Sales to customers $ 1,631 1,559 $ 3,295 3,176
Percent Change (as a percent) 4.70%   3.80%  
PHARMACEUTICAL | Immunology | REMICADE        
Sales by segment of business        
Sales to customers $ 462 647 $ 949 1,310
Percent Change (as a percent) (28.60%)   (27.50%)  
PHARMACEUTICAL | Immunology | REMICADE | U.S.        
Sales by segment of business        
Sales to customers $ 277 391 $ 553 749
Percent Change (as a percent) (29.30%)   (26.20%)  
PHARMACEUTICAL | Immunology | REMICADE | U.S. Exports        
Sales by segment of business        
Sales to customers $ 33 44 $ 74 124
Percent Change (as a percent) (24.90%)   (40.30%)  
PHARMACEUTICAL | Immunology | REMICADE | International        
Sales by segment of business        
Sales to customers $ 152 212 $ 322 437
Percent Change (as a percent) (28.20%)   (26.20%)  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA        
Sales by segment of business        
Sales to customers $ 529 566 $ 1,066 1,137
Percent Change (as a percent) (6.60%)   (6.20%)  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA | U.S.        
Sales by segment of business        
Sales to customers $ 285 301 $ 556 588
Percent Change (as a percent) (5.10%)   (5.40%)  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA | International        
Sales by segment of business        
Sales to customers $ 244 266 $ 510 549
Percent Change (as a percent) (8.20%)   (7.10%)  
PHARMACEUTICAL | Immunology | STELARA        
Sales by segment of business        
Sales to customers $ 2,797 2,599 $ 5,241 4,887
Percent Change (as a percent) 7.60%   7.20%  
PHARMACEUTICAL | Immunology | STELARA | U.S.        
Sales by segment of business        
Sales to customers $ 1,817 1,731 $ 3,268 3,110
Percent Change (as a percent) 4.90%   5.10%  
PHARMACEUTICAL | Immunology | STELARA | International        
Sales by segment of business        
Sales to customers $ 981 868 $ 1,974 1,777
Percent Change (as a percent) 13.00%   11.10%  
PHARMACEUTICAL | Immunology | TREMFYA        
Sales by segment of business        
Sales to customers $ 706 597 $ 1,346 1,187
Percent Change (as a percent) 18.30%   13.40%  
PHARMACEUTICAL | Immunology | TREMFYA | U.S.        
Sales by segment of business        
Sales to customers $ 450 382 $ 856 773
Percent Change (as a percent) 17.80%   10.70%  
PHARMACEUTICAL | Immunology | TREMFYA | International        
Sales by segment of business        
Sales to customers $ 255 214 $ 489 413
Percent Change (as a percent) 19.40%   18.40%  
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY        
Sales by segment of business        
Sales to customers $ 4 3 $ 7 9
Percent Change (as a percent) 17.80%   (30.20%)  
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.        
Sales by segment of business        
Sales to customers $ 4 3 $ 7 9
Percent Change (as a percent) 17.80%   (30.20%)  
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International        
Sales by segment of business        
Sales to customers $ 0 0 $ 0 0
Percent Change (as a percent) 0.00%   0.00%  
PHARMACEUTICAL | Infectious Diseases        
Sales by segment of business        
Sales to customers $ 1,121 1,316 $ 2,707 2,613
Percent Change (as a percent) (14.80%)   3.60%  
PHARMACEUTICAL | Infectious Diseases | U.S.        
Sales by segment of business        
Sales to customers $ 395 415 $ 787 876
Percent Change (as a percent) (4.90%)   (10.20%)  
PHARMACEUTICAL | Infectious Diseases | International        
Sales by segment of business        
Sales to customers $ 727 901 $ 1,920 1,737
Percent Change (as a percent) (19.40%)   10.50%  
PHARMACEUTICAL | Infectious Diseases | COVID-19        
Sales by segment of business        
Sales to customers $ 285 544 $ 1,032 1,001
Percent Change (as a percent) (47.70%)   3.00%  
PHARMACEUTICAL | Infectious Diseases | COVID-19 | U.S.        
Sales by segment of business        
Sales to customers $ 0 45 $ 0 120
PHARMACEUTICAL | Infectious Diseases | COVID-19 | International        
Sales by segment of business        
Sales to customers $ 285 499 $ 1,032 881
Percent Change (as a percent) (43.00%)   17.10%  
PHARMACEUTICAL | Infectious Diseases | EDURANT / rilpivirine        
Sales by segment of business        
Sales to customers $ 266 225 $ 546 473
Percent Change (as a percent) 18.60%   15.60%  
PHARMACEUTICAL | Infectious Diseases | EDURANT / rilpivirine | U.S.        
Sales by segment of business        
Sales to customers $ 8 9 $ 17 18
Percent Change (as a percent) (9.00%)   (5.30%)  
PHARMACEUTICAL | Infectious Diseases | EDURANT / rilpivirine | International        
Sales by segment of business        
Sales to customers $ 258 215 $ 529 454
Percent Change (as a percent) 19.90%   16.40%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA        
Sales by segment of business        
Sales to customers $ 491 464 $ 968 965
Percent Change (as a percent) 5.80%   0.30%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | U.S.        
Sales by segment of business        
Sales to customers $ 382 355 $ 760 724
Percent Change (as a percent) 7.60%   5.00%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | International        
Sales by segment of business        
Sales to customers $ 109 110 $ 208 242
Percent Change (as a percent) (0.20%)   (13.90%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES(        
Sales by segment of business        
Sales to customers $ 79 83 $ 161 174
Percent Change (as a percent) (5.20%)   (7.60%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES( | U.S.        
Sales by segment of business        
Sales to customers $ 5 6 $ 10 14
Percent Change (as a percent) (27.20%)   (30.60%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES( | International        
Sales by segment of business        
Sales to customers $ 74 77 $ 151 160
Percent Change (as a percent) (3.50%)   (5.60%)  
PHARMACEUTICAL | Neuroscience        
Sales by segment of business        
Sales to customers $ 1,793 1,734 $ 3,597 3,475
Percent Change (as a percent) 3.50%   3.50%  
PHARMACEUTICAL | Neuroscience | U.S.        
Sales by segment of business        
Sales to customers $ 1,029 896 $ 2,007 1,739
Percent Change (as a percent) 14.90%   15.40%  
PHARMACEUTICAL | Neuroscience | International        
Sales by segment of business        
Sales to customers $ 764 837 $ 1,590 1,735
Percent Change (as a percent) (8.80%)   (8.40%)  
PHARMACEUTICAL | Neuroscience | CONCERTA / methylphenidate        
Sales by segment of business        
Sales to customers $ 208 161 $ 414 318
Percent Change (as a percent) 28.60%   30.00%  
PHARMACEUTICAL | Neuroscience | CONCERTA / methylphenidate | U.S.        
Sales by segment of business        
Sales to customers $ 64 38 $ 134 73
Percent Change (as a percent) 68.20%   84.00%  
PHARMACEUTICAL | Neuroscience | CONCERTA / methylphenidate | International        
Sales by segment of business        
Sales to customers $ 143 123 $ 279 245
Percent Change (as a percent) 16.30%   13.90%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA        
Sales by segment of business        
Sales to customers $ 1,031 1,054 $ 2,075 2,102
Percent Change (as a percent) (2.10%)   (1.30%)  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | U.S.        
Sales by segment of business        
Sales to customers $ 721 691 $ 1,434 1,352
Percent Change (as a percent) 4.30%   6.00%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | International        
Sales by segment of business        
Sales to customers $ 310 362 $ 641 749
Percent Change (as a percent) (14.40%)   (14.50%)  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE        
Sales by segment of business        
Sales to customers $ 386 433 $ 809 900
Percent Change (as a percent) (10.90%)   (10.10%)  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.        
Sales by segment of business        
Sales to customers $ 100 93 $ 184 179
Percent Change (as a percent) 9.30%   3.10%  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International        
Sales by segment of business        
Sales to customers $ 286 341 $ 625 721
Percent Change (as a percent) (16.40%)   (13.40%)  
PHARMACEUTICAL | Neuroscience | SPRAVATO        
Sales by segment of business        
Sales to customers $ 169 85 $ 300 155
Percent Change (as a percent) 98.20%   93.10%  
PHARMACEUTICAL | Neuroscience | SPRAVATO | U.S.        
Sales by segment of business        
Sales to customers $ 144 74 $ 255 135
Percent Change (as a percent) 93.20%   88.30%  
PHARMACEUTICAL | Neuroscience | SPRAVATO | International        
Sales by segment of business        
Sales to customers $ 25 11 $ 45 20
PHARMACEUTICAL | Oncology        
Sales by segment of business        
Sales to customers $ 4,398 4,042 $ 8,510 7,992
Percent Change (as a percent) 8.80%   6.50%  
PHARMACEUTICAL | Oncology | U.S.        
Sales by segment of business        
Sales to customers $ 2,069 1,679 $ 3,958 3,261
Percent Change (as a percent) 23.20%   21.40%  
PHARMACEUTICAL | Oncology | International        
Sales by segment of business        
Sales to customers $ 2,329 2,362 $ 4,552 4,731
Percent Change (as a percent) (1.40%)   (3.80%)  
PHARMACEUTICAL | Oncology | DARZALEX        
Sales by segment of business        
Sales to customers $ 2,431 1,986 $ 4,695 3,842
Percent Change (as a percent) 22.40%   22.20%  
PHARMACEUTICAL | Oncology | DARZALEX | U.S.        
Sales by segment of business        
Sales to customers $ 1,322 1,021 $ 2,513 1,974
Percent Change (as a percent) 29.50%   27.30%  
PHARMACEUTICAL | Oncology | DARZALEX | International        
Sales by segment of business        
Sales to customers $ 1,110 965 $ 2,182 1,868
Percent Change (as a percent) 15.00%   16.80%  
PHARMACEUTICAL | Oncology | ERLEADA        
Sales by segment of business        
Sales to customers $ 567 450 $ 1,109 850
Percent Change (as a percent) 25.90%   30.40%  
PHARMACEUTICAL | Oncology | ERLEADA | U.S.        
Sales by segment of business        
Sales to customers $ 241 233 $ 490 439
Percent Change (as a percent) 3.60%   11.80%  
PHARMACEUTICAL | Oncology | ERLEADA | International        
Sales by segment of business        
Sales to customers $ 326 218 $ 619 412
Percent Change (as a percent) 49.70%   50.30%  
PHARMACEUTICAL | Oncology | IMBRUVICA        
Sales by segment of business        
Sales to customers $ 841 970 $ 1,668 2,008
Percent Change (as a percent) (13.20%)   (16.90%)  
PHARMACEUTICAL | Oncology | IMBRUVICA | U.S.        
Sales by segment of business        
Sales to customers $ 262 349 $ 532 719
Percent Change (as a percent) (24.90%)   (26.00%)  
PHARMACEUTICAL | Oncology | IMBRUVICA | International        
Sales by segment of business        
Sales to customers $ 579 620 $ 1,136 1,288
Percent Change (as a percent) (6.70%)   (11.80%)  
PHARMACEUTICAL | Oncology | ZYTIGA / abiraterone acetate        
Sales by segment of business        
Sales to customers $ 227 505 $ 472 1,044
Percent Change (as a percent) (55.10%)   (54.80%)  
PHARMACEUTICAL | Oncology | ZYTIGA / abiraterone acetate | U.S.        
Sales by segment of business        
Sales to customers $ 9 19 $ 25 38
Percent Change (as a percent) (55.20%)   (34.70%)  
PHARMACEUTICAL | Oncology | ZYTIGA / abiraterone acetate | International        
Sales by segment of business        
Sales to customers $ 218 486 $ 447 1,006
Percent Change (as a percent) (55.10%)   (55.60%)  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY        
Sales by segment of business        
Sales to customers $ 214 106 $ 376 224
Percent Change (as a percent)     68.00%  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | U.S.        
Sales by segment of business        
Sales to customers 122 33 $ 214 67
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | International        
Sales by segment of business        
Sales to customers $ 92 72 $ 162 156
Percent Change (as a percent) 27.80%   3.60%  
PHARMACEUTICAL | Oncology | CARVYKTI        
Sales by segment of business        
Sales to customers $ 117 24 $ 189 24
PHARMACEUTICAL | Oncology | CARVYKTI | U.S.        
Sales by segment of business        
Sales to customers 114 24 184 24
PHARMACEUTICAL | Oncology | CARVYKTI | International        
Sales by segment of business        
Sales to customers 3 0 5 0
PHARMACEUTICAL | Pulmonary Hypertension        
Sales by segment of business        
Sales to customers $ 972 843 $ 1,844 1,695
Percent Change (as a percent) 15.30%   8.80%  
PHARMACEUTICAL | Pulmonary Hypertension | U.S.        
Sales by segment of business        
Sales to customers $ 684 560 $ 1,284 1,132
Percent Change (as a percent) 22.00%   13.40%  
PHARMACEUTICAL | Pulmonary Hypertension | International        
Sales by segment of business        
Sales to customers $ 289 284 $ 561 563
Percent Change (as a percent) 2.00%   (0.40%)  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT        
Sales by segment of business        
Sales to customers $ 507 438 $ 947 881
Percent Change (as a percent) 15.70%   7.50%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT | U.S.        
Sales by segment of business        
Sales to customers $ 328 265 $ 601 538
Percent Change (as a percent) 23.70%   11.60%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT | International        
Sales by segment of business        
Sales to customers $ 179 173 $ 346 343
Percent Change (as a percent) 3.40%   0.90%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI        
Sales by segment of business        
Sales to customers $ 399 328 $ 761 653
Percent Change (as a percent) 21.80%   16.60%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI | U.S.        
Sales by segment of business        
Sales to customers $ 338 272 $ 642 541
Percent Change (as a percent) 24.20%   18.70%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI | International        
Sales by segment of business        
Sales to customers $ 61 56 $ 119 112
Percent Change (as a percent) 10.00%   6.60%  
PHARMACEUTICAL | Pulmonary Hypertension | Other        
Sales by segment of business        
Sales to customers $ 66 78 $ 136 161
Percent Change (as a percent) (14.70%)   (15.50%)  
PHARMACEUTICAL | Pulmonary Hypertension | Other | U.S.        
Sales by segment of business        
Sales to customers $ 18 23 $ 41 53
Percent Change (as a percent) (23.80%)   (23.00%)  
PHARMACEUTICAL | Pulmonary Hypertension | Other | International        
Sales by segment of business        
Sales to customers $ 48 55 $ 95 108
Percent Change (as a percent) (10.90%)   (11.70%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other        
Sales by segment of business        
Sales to customers $ 950 972 $ 1,877 1,882
Percent Change (as a percent) (2.20%)   (0.30%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.        
Sales by segment of business        
Sales to customers $ 776 757 $ 1,491 1,429
Percent Change (as a percent) 2.60%   4.30%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International        
Sales by segment of business        
Sales to customers $ 174 215 $ 386 453
Percent Change (as a percent) (19.00%)   (14.70%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO        
Sales by segment of business        
Sales to customers $ 637 609 $ 1,215 1,117
Percent Change (as a percent) 4.70%   8.80%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO | U.S.        
Sales by segment of business        
Sales to customers $ 637 609 $ 1,215 1,117
Percent Change (as a percent) 4.70%   8.80%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO | International        
Sales by segment of business        
Sales to customers $ 0 0 $ 0 0
Percent Change (as a percent) 0.00%   0.00%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other        
Sales by segment of business        
Sales to customers $ 313 363 $ 662 765
Percent Change (as a percent) (13.80%)   (13.50%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other | U.S.        
Sales by segment of business        
Sales to customers $ 138 148 $ 275 312
Percent Change (as a percent) (6.30%)   (11.80%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other | International        
Sales by segment of business        
Sales to customers $ 174 215 $ 386 453
Percent Change (as a percent) (19.00%)   (14.70%)  
MEDTECH        
Sales by segment of business        
Sales to customers $ 7,788 6,898 $ 15,269 13,869
Percent Change (as a percent) 12.90%   10.10%  
MEDTECH | U.S.        
Sales by segment of business        
Sales to customers $ 3,839 3,351 $ 7,598 6,576
Percent Change (as a percent) 14.60%   15.50%  
MEDTECH | International        
Sales by segment of business        
Sales to customers $ 3,949 3,547 $ 7,671 7,293
Percent Change (as a percent) 11.30%   5.20%  
MEDTECH | Interventional Solutions        
Sales by segment of business        
Sales to customers $ 1,620 1,049 $ 3,123 2,141
Percent Change (as a percent) 54.40%   45.80%  
MEDTECH | Interventional Solutions | U.S.        
Sales by segment of business        
Sales to customers $ 908 525 $ 1,771 1,019
Percent Change (as a percent) 73.10%   73.80%  
MEDTECH | Interventional Solutions | International        
Sales by segment of business        
Sales to customers $ 712 525 $ 1,352 1,123
Percent Change (as a percent) 35.70%   20.50%  
MEDTECH | ELECTROPHYSIOLOGY        
Sales by segment of business        
Sales to customers $ 1,196 968 $ 2,288 1,970
Percent Change (as a percent) 23.50%   16.20%  
MEDTECH | ELECTROPHYSIOLOGY | U.S.        
Sales by segment of business        
Sales to customers $ 609 499 $ 1,180 969
Percent Change (as a percent) 22.00%   21.70%  
MEDTECH | ELECTROPHYSIOLOGY | International        
Sales by segment of business        
Sales to customers $ 587 469 $ 1,109 1,001
Percent Change (as a percent) 25.10%   10.80%  
MEDTECH | ABIOMED(3)        
Sales by segment of business        
Sales to customers $ 331 0 $ 655 0
MEDTECH | ABIOMED(3) | U.S.        
Sales by segment of business        
Sales to customers 272 0 536 0
MEDTECH | ABIOMED(3) | International        
Sales by segment of business        
Sales to customers 59 0 119 0
MEDTECH | OTHER INTERVENTIONAL SOLUTIONS        
Sales by segment of business        
Sales to customers $ 93 81 $ 180 171
Percent Change (as a percent) 15.10%   5.10%  
MEDTECH | OTHER INTERVENTIONAL SOLUTIONS | U.S.        
Sales by segment of business        
Sales to customers $ 27 26 $ 55 51
Percent Change (as a percent) 4.50%   10.80%  
MEDTECH | OTHER INTERVENTIONAL SOLUTIONS | International        
Sales by segment of business        
Sales to customers $ 67 56 $ 125 121
Percent Change (as a percent) 20.00%   2.80%  
MEDTECH | Orthopaedics        
Sales by segment of business        
Sales to customers $ 2,265 2,157 $ 4,510 4,345
Percent Change (as a percent) 5.00%   3.80%  
MEDTECH | Orthopaedics | U.S.        
Sales by segment of business        
Sales to customers $ 1,388 1,338 $ 2,751 2,627
Percent Change (as a percent) 3.70%   4.70%  
MEDTECH | Orthopaedics | International        
Sales by segment of business        
Sales to customers $ 878 820 $ 1,759 1,719
Percent Change (as a percent) 7.00%   2.30%  
MEDTECH | Orthopaedics | HIPS        
Sales by segment of business        
Sales to customers $ 397 388 $ 787 777
Percent Change (as a percent) 2.20%   1.30%  
MEDTECH | Orthopaedics | HIPS | U.S.        
Sales by segment of business        
Sales to customers $ 250 240 $ 491 465
Percent Change (as a percent) 4.10%   5.60%  
MEDTECH | Orthopaedics | HIPS | International        
Sales by segment of business        
Sales to customers $ 147 148 $ 296 312
Percent Change (as a percent) (0.80%)   (5.10%)  
MEDTECH | Orthopaedics | KNEES        
Sales by segment of business        
Sales to customers $ 363 349 $ 731 688
Percent Change (as a percent) 3.90%   6.30%  
MEDTECH | Orthopaedics | KNEES | U.S.        
Sales by segment of business        
Sales to customers $ 221 216 $ 447 417
Percent Change (as a percent) 2.40%   7.20%  
MEDTECH | Orthopaedics | KNEES | International        
Sales by segment of business        
Sales to customers $ 142 133 $ 284 271
Percent Change (as a percent) 6.30%   4.80%  
MEDTECH | Orthopaedics | TRAUMA        
Sales by segment of business        
Sales to customers $ 739 696 $ 1,496 1,444
Percent Change (as a percent) 6.10%   3.60%  
MEDTECH | Orthopaedics | TRAUMA | U.S.        
Sales by segment of business        
Sales to customers $ 483 464 $ 974 939
Percent Change (as a percent) 4.30%   3.70%  
MEDTECH | Orthopaedics | TRAUMA | International        
Sales by segment of business        
Sales to customers $ 255 232 $ 522 505
Percent Change (as a percent) 9.90%   3.20%  
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER        
Sales by segment of business        
Sales to customers $ 766 724 $ 1,495 1,436
Percent Change (as a percent) 5.80%   4.20%  
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER | U.S.        
Sales by segment of business        
Sales to customers $ 433 418 $ 839 805
Percent Change (as a percent) 3.50%   4.10%  
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER | International        
Sales by segment of business        
Sales to customers $ 334 306 $ 657 630
Percent Change (as a percent) 9.00%   4.20%  
MEDTECH | Surgery        
Sales by segment of business        
Sales to customers $ 2,594 2,450 $ 5,028 4,884
Percent Change (as a percent) 5.90%   3.00%  
MEDTECH | Surgery | U.S.        
Sales by segment of business        
Sales to customers $ 1,015 992 $ 1,990 1,913
Percent Change (as a percent) 2.20%   4.00%  
MEDTECH | Surgery | International        
Sales by segment of business        
Sales to customers $ 1,580 1,458 $ 3,039 2,971
Percent Change (as a percent) 8.40%   2.30%  
MEDTECH | Surgery | ADVANCED        
Sales by segment of business        
Sales to customers $ 1,222 1,156 $ 2,340 2,302
Percent Change (as a percent) 5.80%   1.70%  
MEDTECH | Surgery | ADVANCED | U.S.        
Sales by segment of business        
Sales to customers $ 466 454 $ 910 871
Percent Change (as a percent) 2.70%   4.50%  
MEDTECH | Surgery | ADVANCED | International        
Sales by segment of business        
Sales to customers $ 757 702 $ 1,430 1,431
Percent Change (as a percent) 7.80%   0.00%  
MEDTECH | Surgery | GENERAL        
Sales by segment of business        
Sales to customers $ 1,372 1,294 $ 2,688 2,582
Percent Change (as a percent) 6.00%   4.10%  
MEDTECH | Surgery | GENERAL | U.S.        
Sales by segment of business        
Sales to customers $ 548 538 $ 1,079 1,042
Percent Change (as a percent) 1.90%   3.60%  
MEDTECH | Surgery | GENERAL | International        
Sales by segment of business        
Sales to customers $ 823 756 $ 1,608 1,540
Percent Change (as a percent) 8.90%   4.50%  
MEDTECH | Vision        
Sales by segment of business        
Sales to customers $ 1,308 1,241 $ 2,608 2,498
Percent Change (as a percent) 5.40%   4.40%  
MEDTECH | Vision | U.S.        
Sales by segment of business        
Sales to customers $ 529 496 $ 1,087 1,017
Percent Change (as a percent) 6.60%   6.90%  
MEDTECH | Vision | International        
Sales by segment of business        
Sales to customers $ 778 745 $ 1,521 1,481
Percent Change (as a percent) 4.60%   2.70%  
MEDTECH | Vision | CONTACT LENSES / OTHER        
Sales by segment of business        
Sales to customers $ 939 894 $ 1,892 1,804
Percent Change (as a percent) 5.10%   4.90%  
MEDTECH | Vision | CONTACT LENSES / OTHER | U.S.        
Sales by segment of business        
Sales to customers $ 409 374 $ 853 774
Percent Change (as a percent) 9.10%   10.10%  
MEDTECH | Vision | CONTACT LENSES / OTHER | International        
Sales by segment of business        
Sales to customers $ 530 519 $ 1,039 1,030
Percent Change (as a percent) 2.20%   0.90%  
MEDTECH | Vision | SURGICAL        
Sales by segment of business        
Sales to customers $ 369 347 $ 716 694
Percent Change (as a percent) 6.20%   3.10%  
MEDTECH | Vision | SURGICAL | U.S.        
Sales by segment of business        
Sales to customers $ 120 122 $ 234 243
Percent Change (as a percent) (1.10%)   (3.60%)  
MEDTECH | Vision | SURGICAL | International        
Sales by segment of business        
Sales to customers $ 249 $ 225 $ 482 $ 451
Percent Change (as a percent) 10.10%   6.70%